Elsevier

Brain Research

Volume 405, Issue 1, 3 March 1987, Pages 84-93
Brain Research

Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord

https://doi.org/10.1016/0006-8993(87)90992-9Get rights and content

Abstract

Clonidine and morphine depress nociceptive reflex responses when given alone; when given in combination, the effect of each is potentiated by the other. The present study was designed to test if activity in ascending axons evoked by electrical stimulation of afferent C-fibers in the sural nerve of the rat also exhibits potentiation of the depressant effects of clonidine and morphine when both drugs are administered in combination by intrathecal (i.t.) injection to the lumbar spinal cord. For comparison, experiments were also carried out on the tail-flick response in rats. The results show that (1) clonidine produced a dose-dependent inhibition of the tail-flick response (Ed50 20 μg); (2) a combination of ineffective doses of clonidine (0.3 μg) and morphine (2 μg) significantly inhibited the tail-flick response; (3) clonidine (35 μg) reduced spontaneous, C-fiber-evoked and, due to co-activation, Aδ-fibre-evoked activity in ascending axons; and (4) clonidine at a threshold (0.3 μg) or higher (3 μg) dose administered together with morphine at a dose (2 μg) that caused only a moderate inhibition produced a supra-additive effect in significantly depressing spontaneous, Aδ-and C-fiber-evoked ascending activity. The dose-response curve of depression by morphine alone of C-fiber-evoked activity (ED50 8 μg) is significantly shifted by clonidine to the left (ED50 0.9 μg). Naloxone (0.2mg/kg) injected intravenously did not affect the inhibition of ascending activity caused by clonidine at the highest dose (35 μg), but it reduced the depressant effect of combined i.t. administration of clonidine and morphine. The potentiation of the antinociceptive effects of clonidine and morphine given in combination are possibly due to actions of the two drugs at different sites between the nociceptive afferents and the neurons sending their axons to the brain.

Reference (52)

  • NottM.W.

    Potentiation of morphine analgesia by cocaine in mice

    Eur. J. Pharmacol.

    (1968)
  • OssipovM.H. et al.

    Effect ofα2-adrenergic agents on central etorphine antinociception in the cat

    Brain Research

    (1984)
  • SchmittH. et al.

    Antinociceptive effect of some α-sympathomimetic agents

    Neuropharmacologia

    (1974)
  • SpauldingT.C. et al.

    Antinociceptive activity of clonidine and its potentiation of morphine analgesia

    Eur. J. Pharmacol.

    (1979)
  • SpauldingT.C. et al.

    The dissociation of the antinociceptive effect of clonidine from supraspinal structures

    Neuropharmacology

    (1979)
  • YakshT.L.

    Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray

    Brain Research

    (1979)
  • ZemlanF.P. et al.

    Noradrenergic and serotonergic mediation of spinal analgesic mechanisms

    Eur. J. Pharmacol.

    (1980)
  • Zieglga¨nsbergerW.

    Opioid actions on mammalian spinal neurons

    Int. Rev. Neurobiol.

    (1984)
  • Ande´nN.-E. et al.

    The effect of DOPA on the spinal cord. 1. Influence on transmission from primary afferents

    Acta Physiol. Scand.

    (1966)
  • Ande`nN.-E. et al.

    A new spinal reflex

    Nature (London)

    (1964)
  • AndradeR. et al.

    Opiate andα2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3′:5′- monophosphate analogues

    J. Neurosci.

    (1985)
  • BentleyG.A. et al.

    The actions of soma α-adrenoceptor agonists and antagonists in an antinociceptive test in mice

    Clin. Exp. Pharmacol. Physiol.

    (1977)
  • BernatzkyG. et al.

    Effects of intrathecally administered pentobarbital and naloxone on the activity evoked in ascending axons of the rat spinal cord by stimulation of afferent A and C fibres. Further evidence for a tonic endorphinergic inhibition in nociception

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1983)
  • BlumeW.

    U¨ber die Wirkung des Morphins auf das Ru¨ckenmark der dekapitierten Katze

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1927)
  • BrowningA. et al.

    Interactions of drugs active at opiate and receptors drugs active atα2-receptors on various test systems

    Br. J. Pharmacol.

    (1982)
  • DoiT. et al.

    Intrathecal substance P depresses the tail-flick response-antagonism by naloxone

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1981)
  • Cited by (157)

    • α<inf>2</inf>-agonists and antagonists

      2022, Small Animal Critical Care Medicine
    • Effects of α2-adorenoceptor agonist dexmedetomidine on respiratory rhythm generation of newborn rats

      2015, Neuroscience Letters
      Citation Excerpt :

      In contrast, Tamiya et al. [17] recently demonstrated that the administration of dexmedetomidine induced depression of respiratory rhythm via α2 adrenoceptors in newborn rats in vivo. Regarding antinociceptive effects, α2-adrenoceptors and opioid receptors have important roles at the spinal cord level [18–24]. It has been established that slow ventral root potential induced by ipsilateral dorsal root stimulation in the isolated (typically lumbar) spinal cord of newborn rats reflects nociceptive reflex.

    • α2 agonists and antagonists

      2014, Small Animal Critical Care Medicine, Second Edition
    • Mu-opioid and noradrenergic α<inf>2</inf>-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats

      2011, Pain
      Citation Excerpt :

      Hence, mu-opioid receptor and α2-adrenoceptor actions are simultaneously required for tapentadol’s efficacy, suggesting ongoing synergy between these mechanisms. Synergy between agonists acting at α2-adrenoceptors and MORs has been widely reported and provides the theoretical and practical basis for combination therapies such as tapentadol, and tramadol before it [17,20,30,36]. It could be the case that within its dual mode of action, tapentadol exerts more opioid actions than noradrenergic actions in normal animals, shifting to a prominent noradrenergic analgesic role following neuropathy.

    View all citing articles on Scopus
    View full text